CompaniesDOV Pharmaceuticals

DOV Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

1,982

By Phase

PHASE2: 1PHASE3: 3

By Status

COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00295711
NCT00281645
NCT00295724
Hover over trial bars to see details

Recent Trials

NCT00659347Lead Sponsor
Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
PHASE2Terminated
200 participants
Started: Mar 31, 2008 · Completed: Dec 31, 2008
NCT00295724Lead Sponsor
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
PHASE3Completed
Started: Oct 31, 2005
NCT00281645Lead Sponsor
Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain
PHASE3Completed
1,250 participants
Started: Dec 31, 2004
NCT00295711Lead Sponsor
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
PHASE3Completed
532 participants
Started: Sep 30, 2004
Related Companies
Euthymics----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired
DOV Pharmaceuticals | Biotech Hunter | Biotech Hunter